Background: Vascularized fibula epiphyseal flap was first described in 1998 for proximal humeral reconstruction in children/infants. The authors aim to review their international, multi-institutional, long-term outcomes.
Methods: An international, multi-institutional review (2004 to 2020) was conducted of patients younger than 18 years undergoing free vascularized fibula epiphyseal transfer for proximal humeral reconstruction. Donor- and recipient-site complications, pain, and final ambulatory status were reviewed. Growth of the transferred bone was assessed under the guidance of a pediatric musculoskeletal radiologist.
Results: Twenty-seven patients were included with a median age of 7 years (range, 2 to 13 years). Average follow-up was 120 ± 87.4 months. There were two flap failures (7.4%). Recipient-site complications included fracture [ n = 11 (40.7%)], avascular necrosis of the fibula head [ n = 1 (3.7%)], fibular head avulsion [ n = 1 (3.7%)], infection [ n = 1 (3.7%)], and hardware failure [ n = 1 (3.7%)]. Operative fixation was necessary in one patient with a fracture. The case of infection necessitated fibula explantation 2 years postoperatively, and ultimately, prosthetic reconstruction. Sixteen patients developed peroneal nerve palsy (59.3%): 13 of these cases resolved within 1 year (81% recovery), and three were permanent (11.1%). One patient (3.7%) complained of upper extremity pain. Longitudinal growth was confirmed in all but three cases [ n = 24 (88.9%)] at an average rate of 0.83 ± 0.25 cm/year.
Conclusions: The vascularized fibula epiphysis for proximal humerus reconstruction in children preserves the potential for future growth and an articular surface for motion. Peroneal nerve palsy is common following harvest, although this is often transient. Future efforts should be geared toward reducing postoperative morbidity.
Clinical Question/level Of Evidence: Therapeutic, IV.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PRS.0000000000010001 | DOI Listing |
Ann Thorac Surg
December 2024
Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC; Congenital Heart Surgery Research and Training Laboratory, Duke University, Durham, NC.
World Neurosurg
December 2024
Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, China. Electronic address:
Objective: Currently, there is no established treatment consensus for craniocervical unruptured dissecting aneurysms (UDAs). This study aimed to assess the safety and efficacy of the Surpass Streamline Flow Diverter (SSFD) for treating craniocervical UDAs.
Methods: A retrospective review of three centers' databases was conducted to identify patients with craniocervical UDAs treated with SSFDs from January 2021 to December 2023.
Otol Neurotol
January 2025
Department of Otorhinolaryngology-Head and Neck Surgery, University Medicine Halle, Halle (Saale), Germany.
Objective: To evaluate cochlear implant speech perception among patients with sporadic inner ear schwannoma who underwent ipsilateral implantation.
Study Design: Retrospective multi-institutional cohort study.
Setting: Eleven tertiary academic medical centers across Germany, Denmark, and the United States.
BJU Int
December 2024
Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!